Sign Up
Stories
Drug Companies and Semiconductor Hit Lows
Share
AptarGroup: Sustaining Excellence
Arcus Biosciences Boosts Inducement Gran...
Arcus Biosciences Enhances Employee Bene...
ABIO ARCA Revenue Analysis
ADR Surge and Drops in NY
ARCA Biopharma Revenue Insights
Overview
API
Despite positive earnings and dividends, Pfizer and Biogen hit new lows, along with semiconductor maker Wolfspeed. Analysts downgrade Wolfspeed amid significant earnings decline.
Ask a question
How might the new lows impact the reputation and investor confidence in Pfizer and Biogen?
What factors are contributing to Wolfspeed's significant earnings decline, and can it recover?
What strategies should Pfizer, Biogen, and Wolfspeed consider to attract investors and improve their stock performance?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jan 2024
Feb 2024
Mar 2024
Coverage